PEOPLE - Changes at Vital Signs:
This article was originally published in Clinica
Vital Signs' chief financial officer Tony Dimun will relinquish the post, while staying on the board, the Totowa, New Jersey devices manufacturer has announced. His decision comes against a backdrop of a missed second-quarter profit target and a shortfall in sales following shipping delays.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.